Clinical Trial

Danish Evaluation of Early Catheter Ablation for Atrial Fibrillation in Patients With Heart Failure

Study acronym: DanAblate-HF
Recruiting
View on ClinicalTrials.gov →
Summary
The DanAblate-HF trial will investigate whether early catheter ablation treatment for atrial fibrillation in patients with heart failure is superior to standard treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-15; most recent amendment 2024-08-29.
Status change: Not Yet Recruiting → Recruiting 2024-08-29
Trial Details
NCT Number NCT06560047
Lead Sponsor Aalborg University Hospital
Collaborators: Rigshospitalet, Denmark, Odense University Hospital, Aarhus University Hospital, Zealand University Hospital, Herlev and Gentofte Hospital
Conditions Atrial Fibrillation, Heart Failure
Enrollment 1,616 participants
Start Date 2024-08-28
Primary Completion 2029-08-31 (estimated)
Study Completion 2039-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-30